HTBA’s new Leanara targets the muscle loss problem that GLP-1 drugs don’t solve
HealthTech Bio Actives (HTBA) used Vitafoods Europe 2026 to launch Leanara®, a dual-effect ingredient combining proprietary bioflavonoids with highly bioavailable vitamin B12, formulated specifically to address lean muscle loss and fatigue in consumers using GLP-1 receptor agonist therapies.










